<p>(A) The ability of L1MxN and V1MxN peptides to bind DR1 was measured in a competition binding assay using labeled HA. Different concentrations of photocleavable peptides or unlabeled HA were incubated for 3 days with a 150 nM DR1 and 25 nM labeled HA. Binding of the labeled peptide to DR1 was quantified by fluorescence polarization and the fraction of binding that was inhibited by the unlabeled peptide was calculated and plotted against unlabeled peptide concentration. Squares, circles and triangles show the mean and the error bars represent the standard deviation of two independent experiments done with triplicate samples. (B) DR1-L1MxN (left panel) and DR1-V1MxN (right panel) were not exposed (grey trace) or exposed 5 (light blue) and ...
<p>Synthetic TMD peptides were fluorescently tagged with fluorescein (TLR2) or coumarin (TLR1, TLR6)...
Cytotoxic T lymphocytes (CTL) recognize peptides in association with major histocompatibility comple...
Peptide binding to major histocompatibility complex class II (MHCII) molecules is a key process in a...
<p>(A) The ability of photoHA, Ac-photoHA, Ac-photoHAΔ<sub>1–2</sub> and photoHAΔ<sub>1–2</sub> to b...
<p>The ability of Y1MxN photocleavable peptide to bind DR1 was measured in a competition binding ass...
<p>(A) 150 nM DR1 empty was exposed to UV light for different periods of time (20 minutes, blue trac...
<p>(A) 150 nM DR1-Y1MxN was exposed to UV light on ice during 20 minutes and incubated on ice for di...
<p>DR1 is in its peptide receptive conformation when is bound to a peptide, in this case, a photocle...
Major Histocompatibility Complex class II (MHC-II) molecules bind peptides and present them to recep...
<p>(A) Association (left) and dissociation (right) of HA(306–318) peptide to DR1 molecules with no a...
Using a direct binding assay based on photoaffinity labeling, we have studied the interaction of ant...
<div><p>Major Histocompatibility Complex class II (MHC-II) molecules bind peptides and present them ...
<p>(A) The photo-reactive group, 3-amino-3-(2-nitrophenyl)-propionyl (highlighted with a black dashe...
<p>(A) Association (left) and dissociation (right) of CII(259–273) peptide to DR1 molecules with no ...
<p>(a) Competitive binding analysis of P1, P3 and P7 MTSL-Cys substituted HA peptide variants to DR1...
<p>Synthetic TMD peptides were fluorescently tagged with fluorescein (TLR2) or coumarin (TLR1, TLR6)...
Cytotoxic T lymphocytes (CTL) recognize peptides in association with major histocompatibility comple...
Peptide binding to major histocompatibility complex class II (MHCII) molecules is a key process in a...
<p>(A) The ability of photoHA, Ac-photoHA, Ac-photoHAΔ<sub>1–2</sub> and photoHAΔ<sub>1–2</sub> to b...
<p>The ability of Y1MxN photocleavable peptide to bind DR1 was measured in a competition binding ass...
<p>(A) 150 nM DR1 empty was exposed to UV light for different periods of time (20 minutes, blue trac...
<p>(A) 150 nM DR1-Y1MxN was exposed to UV light on ice during 20 minutes and incubated on ice for di...
<p>DR1 is in its peptide receptive conformation when is bound to a peptide, in this case, a photocle...
Major Histocompatibility Complex class II (MHC-II) molecules bind peptides and present them to recep...
<p>(A) Association (left) and dissociation (right) of HA(306–318) peptide to DR1 molecules with no a...
Using a direct binding assay based on photoaffinity labeling, we have studied the interaction of ant...
<div><p>Major Histocompatibility Complex class II (MHC-II) molecules bind peptides and present them ...
<p>(A) The photo-reactive group, 3-amino-3-(2-nitrophenyl)-propionyl (highlighted with a black dashe...
<p>(A) Association (left) and dissociation (right) of CII(259–273) peptide to DR1 molecules with no ...
<p>(a) Competitive binding analysis of P1, P3 and P7 MTSL-Cys substituted HA peptide variants to DR1...
<p>Synthetic TMD peptides were fluorescently tagged with fluorescein (TLR2) or coumarin (TLR1, TLR6)...
Cytotoxic T lymphocytes (CTL) recognize peptides in association with major histocompatibility comple...
Peptide binding to major histocompatibility complex class II (MHCII) molecules is a key process in a...